IP Library Granted Patent US 9,334,328
Granted Patent B2
US 9,334,328 · App. 13/739,212 · Granted May 10, 2016

Modified nucleosides, nucleotides, and nucleic acids, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,334,328
App. No.
13/739,212
Granted
May 10, 2016
Kind
B2
Abstract

The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using thereof.

Claims (13)

1. A method of synthesizing a ribonucleic acid (RNA), comprising the steps of:

a) providing a complementary deoxyribonucleic acid (cDNA) that encodes a protein of interest;

b) selecting a nucleotide that is known to disrupt a binding of a major groove binding partner with a RNA, wherein the nucleotide has decreased binding affinity to the major groove binding partner selected from the group consisting of toll-like receptor (TLR) 3, TLR7, TLR8, retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2), and wherein the nucleotide comprises a modification on the major groove face of the nucleobase where an atom of the major groove face of the nucleobase is replaced or substituted with an alkyl group; and

c) contacting the provided cDNA and the selected nucleotide with an RNA polymerase, under conditions such that the RNA is synthesized.

2. The method of claim 1 , wherein the ribonucleic acid (RNA) is a messenger RNA (mRNA).

3. The method of claim 1 , wherein the major groove binding partner is TLR3.

4. The method of claim 1 , wherein the major groove binding partner is TLR7.

5. The method of claim 1 , wherein the major groove binding partner is TLR8.

6. The method of claim 1 , wherein the major groove binding partner is RIG-I.

7. The method of claim 1 , wherein the major groove binding partner is MDA5.

8. The method of claim 1 , wherein the major groove binding partner is LGP2.

9. The method of claim 1 , wherein the nucleobase comprising a modification on the major groove face is a pyrimidine nucleobase.

10. The method of claim 2 , wherein the nucleobase comprising a modification on the major groove face is a pyrimidine nucleobase.

Assignments (9)
SECURITY INTEREST Recorded Nov 19, 2025
From: MODERNATX, INC.
To: ARES CAPITAL CORPORATION, AS AGENT
Reel/Frame 073634/0354 →
CHANGE OF NAME Recorded May 12, 2017
From: MODERNA THERAPEUTICS, INC.
To: MODERNATX, INC.
Reel/Frame 042457/0482 →
CHANGE OF NAME Recorded Oct 5, 2016
From: MODERNA THERAPEUTICS
To: MODERNATX, INC.
Reel/Frame 040233/0082 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME FROM MODERNA THERAPEUTICS TO MODERNA THERAPEUTICS, INC. PREVIOUSLY RECORDED AT REEL: 029678 FRAME: 0326. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 19, 2014
From: SCHRUM, JASON P.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 034687/0599 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 029678 FRAME: 0524. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 18, 2014
From: SIDDIQI, SUHAIB
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 034660/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2014
From: EJEBE, KENECHI, DR.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 033850/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2014
From: FLAGSHIP VENTURES
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 033245/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2013
From: SCHRUM, JASON P.
To: MODERNA THERAPEUTICS
Reel/Frame 029678/0326 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2013
From: SIDDIQI, SUHAIB
To: MODERNA THERAPEUTICS
Reel/Frame 029678/0524 →